Abstract
Due to the fairly dismal prognosis often associated with cancer of the gastrointestinal tract, chemotherapy as an adjuvant to surgery was a logical development for high-risk patients likely to develop recurrence. It was thought merely necessary to await the availability of compounds that showed reasonable effectiveness against such cancers. Regrettably the wait has been a long one and, to a large extent, still prevails.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Moertel, C. G. and Reitemeier, R. J. (eds.) (1969). Advanced Gastrointestinal Cancer, p. 6. (New York: Harper & Row)
Moertel, C. G., Childs, D. S., Jr, Reitemeier, R. J. et al (1969). Combined chemotherapy and radiation therapy. In Moertel, C. G. and Reitemeier, C. G. (eds.). Advanced Gastrointestinal Cancer, pp. 192–204. (New York: Harper & Row).
Ansfield, Fred J. (1973) Chemotherapy of Malignant Neoplasm, p. 229 (Springfield, 111: Charles C. Thomas)
Hattori, T., Niimoto, M., Koh, T. et al (1979). Post-operative long-term adjuvant immunochemotherapy with miyomycin-C, PSK and FT-207 in gastric cancer patients. Jpn. J. Surg., 9, 110
Fujimoto, S., Akao, T., Itoh, B. et al (1977). Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer. Ann. Surg., April
Gilbert, J. M., Ellis, H., Wastell, C. et al (1978). Adjuvant treatment with razoxane (ICRF 159) following resection of cancer of the stomach. Rec. Results Cancer Res., 68, 217
Cole, W. H., Roberts, S. S. and Strehl F. W. (1966). Modern concepts in cancer of the colon and rectum. Cancer, 19, 1347
Turnbull, R. B., Kyle, K., Watson, F. R. et al (1967). Cancer of the colon: The influence of the no-touch isolation technique on survival rates. Ann. Surg., 166, 420
National End Results Committee.
Falterman, K. W., Hill, C. B., Markey, J. C. et al (1974). Cancer of the colon, rectum, anus: a review of 2313 cases. Cancer, 34, 951
Weiss, R. B. and De Vitta, V. T., Jr (1979). Multimodal primary cancer treatment (adjuvant chemotherapy): current results and future prospects. Ann. Intern. Med., 91, 251
Mrazek, R., Economou, S., Monald, G. O. et al (1959). Prophylactic and adjuvant use of nitrogen mustard in the surgical treatment of cancer. Ann. Surg., 150, 74
Dwight, R. W., Higgins, G. A. and Keehan, R. J. (1969). Factors influencing survival after resection in cancer of the colon and rectum. Am. J. Surg., 117, 512
Higgins, G. A., Serlin, O., Hughes, F. et al (1962). The Veterans Administration Surgical Adjuvant Group-Interim report. Cancer Chemother. Rep., 16, 141
Holden, W. D., Dbcon, W. J. and Kuzma, J. W. (1967). The use of triethylenethiophosphoramide-adjuvant to the surgical treatment of colorectal carcinoma. Ann. Surg., 165, 481
Dixon, W. J., Longmire, W. P. and Holden, W. (1971). Use of triethylenethiophosphamide as an adjuvant to the surgical treatment of gastric and colorectal carcinoma — Ten year followup. Ann. Surg., 173, 26
Heidelberger, C., Chaudhuri, N. K., Danneberg, P. et al. (1957). Fluroinated pyrimidines; a class of tumor-inhibitory compounds. Nature (Lond.), 179, 663
Duschinsky, R., Pleven, E. and Heidelberger, C. (1957). The synthesis of 5-fluoropyrimidines. J. Am. Chem. Soc., 79, 4559
Heidelberger, C., Griesbach, L., Cruz, O. et al. (1958). Studies on fluorinated pyrimidines. VI. Effects of 5-fluorouridine and 5-fluoro-2’-deoxyuridine on transplanted tumors. Proc. Soc. Exp. Biol. Med., 97, 470
Ansfield, F.J. and Curreri, A. R. (Division of Clinical Oncology, University of Wisconsin, Madison) (1963). Further clinical comparison between 5-fluorouracil (5-FU)1 and 5-fluoro-2’-doxyuridine (5-FUDR). Cancer Chemother. Rep., No. 32
Higgins, G. A., Dwight, R. W., Smith, J. V. et al. (1971). Fluorouracil as an adjuvant to surgery in carcinoma of the colon. Arch. Surg., 102, 339
Moertel, C. G., Reitemeier, R. J. and Hahn, R. G. (1969). Therapy with the fluorinated pyrimidines. In Moertel, C. G. and Reitemeier, R. J. (eds.). Advanced Gastrointestinal Cancer, pp. 86–107. (New York: Harper & Row)
Grage, T. B., Metter, G. E., Cornell, G. N. et al. (1977). Adjuvant chemotherapy with 5-fluorouracil after surgical resection of colorectal carcinoma (COG Protocol 7041). A preliminary report. Am. J. Surg., 133, 59
Rousselot, I. M., Cole, D. R., Grossi, C. E. et al. (1968). A five year progress report on the effectiveness of intraluminal chemotherapy (5-fluorouracil) adjuvant to surgery for colorectal cancer. Am. J. Surg., 115, 140
Lawrence, W., Terz, J. J., Horsley, S. et al. (1975). Chemotherapy as an adjuvant to surgery for colorectal cancer. Ann. Surg., 181, 616
Higgins, G. A., Jr, Humphrey, E., Juler, G. L. et al. (1976). Adjuvant chemotherapy in the surgical treatment of large bowel cancer. Cancer, 38, 1461
Dwight, R. W., Humphrey, E. W., Higgins, G. A. et al (1973). FUDR as an adjuvant to surgery in cancer of the large bowel. J. Surg. Oncol., 5, 243
Ramirez, G., Korbitz, B. C., Davis, H. L., Jret al. (1969). A comparative study of monthly courses vs. weekly maintenance dose of 5-fluorouracil (NSC 19893). Cancer Chemother. Rep., 53, 243
Ansfield, F. J. (1964). A less toxic fluorouracil dosage schedule. J. Am. Med. Assoc., 190, 686
Wolberg, W. H. and Morin, J. (1981). Thymidylate synthetase activity and fluorouracil sensitivity of human colonic cancer and normal mucosal tissue preparations. Cancer (In press)
Ansfield, F. J. and Curreri, A. R. (1958), Clinical studies with 5-fluorouarcil. Proc. Am. Assoc. Cancer Res., 2, 276
Ansfield, F. J., Klotz, J., Nealon, T. et al. (1977). A Phase III study comparing the clinical utility of four regimens of 5-fluorouracil — a preliminary report. Cancer, 39, 34
Skipper, H. E. (1978). Adjuvant chemotherapy. Cancer, 41, 936
Schabel, F. M., Jr (1975). Concepts for systemic treatment of micrometastases. Cancer, 35, 15
Li, M. C. and Ross, S. T. (1976). Chemoprophylaxis for patients with colorectal cancer: prospective study with five-year follow-up. J. Am. Med. Assoc., 235, 2825
Jacobs, E. M., Reeves, W. J., Wood, D. A. et al. (1971). Treatment of cancer with weekly intraveous 5-fluorouracil. Cancer, 27, 1302
Curreri, A. R. and Mackman, S. (1966). Reoperation in carcinoma of the colon following resection and adjuvant chemotherapy. Surg. Gynecol. Obstet., 123, 724
Mackman, S. and Curreri, A. R. (1968). The second look operation for carcinoma of the colon after administration of 5 FU. Am. J. Surg., 115, 227
Mackman, S., Curreri, A. R. and Ansfield, F. J. (1970). Second-look operation for colon carcinoma after 5-FU therapy. Arch. Surg., 100, 527
Mackman, S., Ansfield, F. J., Ramirez, G. et al. (1974). A second look at the secondlook operation in colonic cancer after the administration of fluorouracil. Am. J. Surg., 128, 763
Buroker, T., Kim, P. N., Groppe, C. et al. (1978). 5-FU infusion with mitomycin-C versus 5-FU infusion with methyl-CCNU in the treatment of advanced colon cancer: a Southwest Oncology Group Study. Cancer, 42, 1228
Falkson, G. and Falkson, H. C. (1976) Fluorouracil, methyl CCNU, and vincristine in cancer of the colon. Cancer, 38, 1468
Moertl, C. G., Schutt, A. J., Hahn, R. J. et al. (1975). Therapy of advanced colorectal cancer with a combination of 5-FU, methyl 1,3 eis (chloroethyl)-l-cyclohexyl nitrosourea and vincristine. J. Natl. Cancer Inst., 54, 69
Higgins, G. A., Jr, Humphrey, E. W., Amadeo, J. H. et al. (1977). Preoperative radiotherapy for colorectal cancer. In Gerard, A. (ed.). Gastrointestinal Tumors: a Clinical and Experimental Approach (Proceedings of an International Symposium sponsored by the European Organization for Research and Treatment of Cancer, Brussels, 14–15 April)
Buroker, T., Nigro, N., Correa, J. et al. (1976). Combination preoperative radiation and chemotherapy in adenocarcinoma and the rectum. Dis. Colon Rectum, 19, 660
Kligerman, M. M., Urdaneta, N., Knowlton, A. et al. (1972), Preoperative irradiation of rectosigmoid carcinoma including its regional lymph nodes. Am. J. Roentgenol, 114, 498
Quan, S. H., Deddish, M. R. and Stearns, M. W. Jr (1960). The effect of preoperative roentgen therapy upon the 10 and 5 yr results of the surgical treatment of cancer of the rectum. Surg. Gynecol Obstet., III, 507
Turner, S. S., Vieira, E. F., Ager, P. J. et al (1977). Elective postoperative radiotherapy for locally advanced colorectal cancer. Cancer, 40, 105
Moertel, C. G., Ritts, R. E., Schutt, A. J. et al (1975). Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guerin as an immunostimulant in patients with advanced cancer. Cancer Res., 35, 3075
Moertel, C. G., O’Connell, M. J., Ritts, R. E., Jr et al (1978). A controlled evaluation of combined immunotherapy (MER-BCG) and chemotherapy for advanced colorectal cancer. In Terry, W. D. and Windhurst, D. (eds.). Immunotherapy of Cancer: Present Status of Trials in Man. (New York; Raven Press)
Valdivieso, M. and Mavligit, G. M. (1978), Chemotherapy and chemoimmunotherapy of colorectal cancer — role of the carcinoembryonic antigen. Symposium on Colon and Anorectal Surgery. Surg. Clin. N. Am., 58, 619
Pannettiere, F. J. and Jones, S. E. (eds.) (1977). Adjuvant chemotherapy and chemoimmunotherapy for locally advanced large bowl adenocarcinoma. Preliminary report of a continuing Southwest Oncology Group Study. Adjuvant Therapy of Cancer (Amsterdam: Elsevier/North-Holland Biomedical Press)
Robinson, E., Batal, A., Cohen, Y. et al (1979). Adjuvant therapy in colorectal cancer (a randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with the Methanol Extraction Residue of BCG, MER). Biomedicine, 31, 8
Wolberg, W. H., Johnson, R. O. and Curreri, A. R. (1960). Toxicity studies of 5-flurouracil used as an adjuvant to surgery. Am. Med. Assoc. Arch. Surg., 81, 244
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 MTP Press Limited
About this chapter
Cite this chapter
Ansfield, F.J., Ramirez, G. (1982). Adjuvant therapy of gastrointestinal carcinoma. In: Jirsch, D.W. (eds) Frontiers in General Surgery. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6642-3_5
Download citation
DOI: https://doi.org/10.1007/978-94-011-6642-3_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-6644-7
Online ISBN: 978-94-011-6642-3
eBook Packages: Springer Book Archive